. It is of course entirely possible that not all conditions and factors that drive the various T cell phenotypes have been identified, but it is equally likely that there are some T cell programmes that are more related than others. For instance, although T cells producing IL9 do not pro duce IL4 they are nevertheless associated with T H 2type responses such as helminth specific immune responses or allergy.
Jeffrey A. Bluestone. It is increasingly clear that certain subsets of T cells defined by their function and by the expression of a particular transcription factor are not necessarily stable. We and other groups recently reported that some forkhead box P3 (FOXP3) + T regulatory (T Reg ) cells lose FOXP3 expression and take on an effector memory T cell phenotype [4] [5] [6] , producing interferonγ (IFNγ), and in some instances have the potential to cause rapid pancreatic cell destruction and immune mediated diabetes 5 . Moreover, in humans a subset of activated T Reg cells with low FOXP3 expression levels that have lost their suppres sor function and produce more IL17 as a population percentage than any other CD4 + T cell fraction analysed has been described 7 . Importantly, the proportion of this FOXP3 low T Reg cell population is increased in the blood during active systemic lupus erythematosus. Thus, T Reg cells that have lost their suppressor function and are potentially pathogenic have been described in healthy mice and in patients with autoimmune disease and may have a role in autoimmunity.
Charles R. Mackay. The definition of effector T cell subsets has been somewhat arbitrary but usually relates to the cytokines that they produce, the transcription factors expressed and in some cases the chemo attractant receptors expressed. T cell subsets defined by the expression of CD4 or CD8, or by the presence of αβ and γδ T cell receptors (TCRs), are inflexible and are determined during ontogeny in the thymus, whereas the turning on or off of transcription factors in peripheral T cells and the gene expression programmes driven by these transcrip tion factors, for example those encoding cytokines and chemokine receptors, are much more flexible. The degree of flexibility between subsets should become clearer as we gain a better understanding of the molecular nature of all the transcription factors that determine T cell subset fate.
There are now several clear examples that show that T cells can be flexible. However, it is unlikely that a given subset can transform to any and every other subset. Perhaps the T cell subset that has the greatest potential for flexibility with respect to origin is T follicular helper (T FH ) cells, the T effector cell subset that provides help to B cells and supports antibody class switching in germinal centres. T FH cells can develop independently of other effector T cell subsets 8 Three studies used IL4 reporter mice [9] [10] [11] and showed that, during helminth infec tion, most IL4expressing CD4 + T cells also expressed the T FH cell markers CXCR5, programmed cell death protein 1 (PD1), inducible T cell costimulator (ICOs), B cell lymphoma 6 (BCL6) and IL21 and local ized to the B cell follicles. However, they also expressed GATA3, which is the main transcription factor for T H 19, 20 . Many of the classical studies that led to our current notion of T cell lineages have relied heavily on extensive in vitro manipu lation; it is less well established whether T cells generated in vivo follow the same rules. Moreover, human effector T cells are often more flexible in terms of cytokine production than their mouse counterparts. These data beg the question: why should we think that cytokine production by T cell subsets is not flexible?
Although the distinction between line ages and subsets may seem pedantic, the term lineage implies stability of phenotype, whereas the term subset does not. The concept of lineage commitment arises from developmental biology and has strong biological and molecular underpinnings. The terms lineage commitment and cell fate determination refer to the programming of a cell to follow a specified path, often resulting in terminal differentiation, and immediately imply limited flexibility. so, is it more accu rate to characterize T cells that selectively produce certain cytokines as subsets or lineages? Is the distinction useful or is it just semantics? If T H cells are just subsets, then it is not a big deal -sometimes they make cytokines and sometimes they do not; there is no requirement that a subset necessarily behaves like a terminally differentiated cell. However, the issue of flexibility in immune responses is clearly not just semantics for those interested in manipulating immune responses in a therapeutically useful manner. If the goal is to understand the molecular basis of specification, it is important to know when T cells are committed to a fate and when they are just making cytokines, and what the determining factors are for the dif ference. Moreover, when the terms are not used appropriately we can become prisoners of our own semantics; clearly it is timely to revisit how we think of T H cell subsets and what commitment means. Fortunately, more genetic tools are becoming available to care fully map the fates of immune cells in vivo in the setting of homeostasis and infection. 
Asymmetrical cell division
A type of division that produces two daughter cells with different properties. This is in contrast to normal cell division, which give rise to equivalent daughter cells. Notably, stem cells can divide asymmetrically to give rise to two distinct daughter cells: one copy of themselves and one cell programmed to differentiate into another cell type.
Class switching
The switch from expressing IgM to expressing other isotypes such as IgG, IgA or IgE that some B cells make after recognizing their cognate antigen. The decision of which isotype is generated is strongly influenced by the specific cytokine milieu and other cells such as T helper cells.
Germinal centre
A highly specialized and dynamic microenvironment that gives rise to secondary B cell follicles during an immune response. It is the main site of B cell maturation, leading to the generation of memory B cells and plasma cells, which produce high-affinity antibody.
Lymphoid-tissue inducer cell
A cell that is present in developing lymph nodes, Peyer's patches and nasopharynx-associated lymphoid tissue (NALT) and is required for the development of these lymphoid organs.
Lymphopenic mice
Mice that have lost both B and T cells, for example severe combined immunodeficiency mice or recombination activation gene-deficient mice, which lack an enzyme required for the generation of T and B cell receptors, or a loss of T cells only, as seen in nu/nu mice, which lack a thymus. T cell lymphopenia can be induced in mice by thymectomy on day three of life.
MicroRNAs
Small RNA molecules that regulate the expression of genes by binding to the 3ʹ-untranslated regions of specific mRNAs.
Non-obese diabetic (NOD) mice
NOD mice spontaneously develop type 1 diabetes mellitus as a result of autoreactive T cell-mediated destruction of pancreatic β-islet cells.
Peyer's patches
Collections of lymphoid tissue located in the mucosa of the small intestine, with an outer epithelium layer consisting of specialized epithelial cells called M cells.
Systemic lupus erythematosus
(SLE). An autoimmune disease in which autoantibodies that are specific for DNA, RNA or proteins associated with nucleic acids form immune complexes that damage small blood vessels, particularly in the kidney. Patients with SLE generally have abnormal B and T cell function.
T follicular helper (T FH ) cell
A CD4 + T cell that provides help to B cells in follicles and germinal centres. The T FH cell signature includes the expression of CXCR5, ICOS, CD40 ligand and IL-21, factors that mediate T FH cell homing to follicles and B cell help.
also induce cell differentiation in response to other signals. The changes associated with lineage commitment are hereditable, and various epigenetic modifications ensure that this is the case; even without continued external stimulation, cell identity can remain stable owing to these modifications 21, 22 . In addition, cell polarity is another important factor that influences the lineage commitment of daughter cells.
viewed from this perspective, a legitimate argument can be made that dif ferentiation of T H cells looks like lineage com mitment. Cytokines provide morphogenlike signals that induce the expression of line agespecifying transcription factors, which belong to the same families that drive devel opment in model organisms (for example Tbet, GATA3, H2.0like homeobox (HLX) and sTATs). Recent evidence points to an instructive role of cytokines in lineage deter mination, above and beyond their effects on cell survival 23 . Lineagedefining cytokine genes also have the expected permissive and repressive epigenetic marks 17 . However, lineage commitment does not exclude reversibility -it does not necessar ily imply terminal differentiation. Classically, lineage commitment is divided into two phases: specification and determination. specified lineage commitment denotes that cells differentiate autonomously under neutral conditions but that this commit ment can be reversed. By contrast, a tissue that is determined is irreversibly committed. Determination is followed by differentiation, which is shown by biochemical, structural, functional and histological changes. so it is probably more precise to think of lineage commitment in all T cells as not being 'deter mined' (as in segmentation or organogenesis). Rather, subsets of cytokineproducing T cells seem to have undergone a process more like specification, meaning that although differentiation occurs, opportunities for alternative fates persist. Consistent with this idea is the observation that epigenetic marks of genes encoding the master regulators Tbet (T H 1 cells) and GATA3 (T H 2 cells) are not uniformly repressed in opposing line ages; such lineages have bivalent epigenetic marks, indicating that both permissive and repressive epigenetic marks are present 17 . Furthermore, the epigenetic modifications of genes that contribute to aspects of T H cells beyond the lineagedefining cytokine genes (for example, genes encoding other cytokines and chemo kine receptors) do not necessarily conform to a simple view of a T H cell pheno type. The good news is that advances in the understanding of epigenetic regulation along with new technologies allow these changes to be measured across the genome. Another factor that has clearly been documented to affect the stability of T H cells is microRNAs (miRNAs). For instance, T Reg cells deficient for the miRNA processing enzymes Dicer and Drosha (also known as ribonuclease 3) are unstable, downregulate FOXP3 expres sion and may become effector T cells 24 . Thus, miRNAs seem to be important in preserving cellular phenotype, and emerging discoveries that relate to the interplay between chromatin modifications, miRNA and large noncoding RNAs should be watched closely. 
C.R.M.
The cellular and molecular signals associated with germinal centre reactions seem to be necessary for
IL4
+ T cells) were shown to transform into T FH cells in recipient mice, but only when they had a normal B cell system and could form germinal centres 19 . ICOs-ICOs ligand and CD40-CD40 ligand interactions were also shown to be important for T FH cell development 9, 11 , regardless of whether the cells developed from T H 2like cells or from activated (unpolarized) T cells. In addition, IL6 and IL21 are two extrinsic factors that promote T cell differentiation to the T FH cell phenotype 8, 25 or that mediate upregulation of BCL6 (an important transcription fac tor for T FH cell development) expression in T cells (see below).
J.A.B.
The microenvironment seems to instruct the outcome of functional change of differentiated T cells. For example, under normal conditions, we have found that T cells that once expressed FOXP3 (which we have termed exFOXP3 cells) produced IFNγ in the spleen, liver and peripheral lymph nodes but produced IL17A in gutassociated lymphoid tissues 6 . In vitro studies have shown that IL6, TGFβ and other unidentified dendritic cellsecreted, and possibly epithelial cellsecreted, factors can modulate T Reg cell function and FOXP3 expression 5, 26, 27 . There is also growing evidence that other inflammatory cytokines, retinoic acid, Tolllike receptor (TLR) ligands and perhaps lymphopenia can alter T Reg cell stability and function.
In fact, low levels of subsetpromoting cytokines may also control plasticity. IL2 induced sTAT5 activation is required for T Reg cell development and survival 28, 29 . The T Reg cellspecific determining region in an intron of Foxp3 contains a sTAT5 binding site 30 and T Reg cells with low IL2Rα
(also known as CD25) expression levels are unstable and lose FOXP3 expression when transferred to lymphopenic mice or in an IL2deficient autoimmune setting 4, 6 . In non-obese diabetic (NOD) mice, intraislet T Reg cells express decreased levels of IL2Rα 31 , and a subset of these cells loses FOXP3 expression 6 . Treatment with a low dose of recombinant IL2 restores IL2Rα expres sion and increases T Reg cell numbers in the pancreas to provide protection from diabetes 31 . Determining the hierarchy of factors that promote stability or plasticity will be crucial for therapeutic interventions.
B.S.
It is likely that plasticity is determined by the sum of interactions with antigen presenting cells and stromal cells in the environment of initial activation. It was shown in cell culture experiments that T cells develop different cell fates as a consequence of random encounters with antigen presenting cells and cytokines that last for different time periods 32 . This was deter mined for effector and memory T cell fates but may similarly apply to the degree of plasticity in adopting distinct effector T cell profiles. However, it is difficult to follow such events on the singlecell level in vivo and one can only hope that future advances in intravital microscopy techniques will facilitate these kinds of analyses 33 . Cytokines are important factors that drive CD4 + effector T cell differentiation, and paradigms for T H 1, T H 2 and T H 17 cell differentiation in response to distinct cytokines have been established. However, it is clear that effector T cell subsets generated in vitro are not exposed to the full range of mediators that may influence differentiation in vivo. In vitro conditions lack multiple factors secreted by other cells types present in the physiological environment, such as stromal cells, and the in vitro use of anti bodies to the TCR or high doses of peptide and antigenpresenting cells artificially enhances T cell activation. It is therefore dif ficult to be sure to what degree CD4 + effector T cell subsets that are generated in vitro bear the hallmarks of those that arise in vivo. 6 . We argue that global epigenetic changes can 'lock' differentiated T cells into certain functional and phenotypic subsets but that under certain immune insults these T cells retain some plasticity 29 . Recent studies by Reiner and colleagues 34 showing asymmetrical cell division can influence T cell subset stability. so, extrinsic factors and the microenvironment probably determine stability versus flexibility during population expansion so that the daughter chromatin might keep or change its epigenetic status 5, 35 . B.S. Quantitative differences in the expression of numerous external factors can influence T cell lineage commitment. As an example, T H 17 cells are influenced by numerous cytokines as well as environ mental signals through activation of the transcription factor aryl hydrocarbon receptor (AHR). IL6 and TGFβ are neces sary and sufficient to drive initial T H 17 cell differentiation, but other cytokines such as IL1β and autocrine IL21 enhance this step. Furthermore, there is an absolute requirement for IL23 for the maintenance and function of T H 17 cells in vivo 36 ; however, this cytokine is dispensable for in vitro differentiation 37 . In addition, activation of AHR is essential to drive the expression of IL22 in T H 17 cells 38 .
What regulates lineage commitment versus flexibility?

J.A.B. This question raises other fundamental questions: what is a T cell lineage versus a T cell subset versus a T cell differentiation
A particularly poignant reminder of the potential artefacts encountered with in vitro systems is the demonstration that T H 17 cell polarization works better in some culture media than others, partly owing to the dif ferential presence of natural AHR ligands 39 . Thus, it is possible that T H 17 cells exposed to all these factors are more committed to their programme than those that encounter only a few of these influences.
In terms of flexibility, in the case of T H 17 cells it is interesting that they express recep tors for both IL12 and IL23 and are thus susceptible to the action of IL12, which pos itively regulates Tbet expression 40 , poten tially allowing for T H 17 to T H 1 cell plasticity. This would be in line with data from Wei et al. 17 who showed that some transcription factors such as Tbet display bivalent epi genetic modifications that may allow rapid transition between repressive and active states. Thus, lineage commitment versus flexibility is influenced by numerous sig nals and extrinsic influences that shape the molecular programme of a T cell. Findings from in vitro conditions will always be just a snapshot of the potential in vivo influences that a T cell experiences.
C.R.M.
We and others showed recently that the transcriptional repressor BCL6 directs T FH cell lineage differentiation 41 . It does this by turning on an extensive gene repressor programme that inhibits key transcriptional regulators of other T H cell lineages, includ ing Tbet, RORγt and GATA3 (REFS 41, 42) . Our studies suggest that BCL6 can repro gramme T H 1, T H 2 and T H 17 cells to a T FH cell phenotype, although whether this is reversible is uncertain. BCL6 also repressed the transcription of a large number of miRNAs, many of which negatively regu late, or are predicted to regulate, key T FH cellassociated molecules, such as CXCR5, IL21 and ICOs 41 . T FH cells are distinguished from nonT FH effector T cells only through a quantitative increase in the expression of molecules such as CXCR5, CXCR4, PD1, ICOs and IL21, and so repression of miRNA may be essential for differentiation to the T FH cell phenotype. Repression (or not) of these miRNAs would allow for flex ibility in the expression of cytokines and chemokine receptors that are associated with T effector cells. In addition, we found that overexpression of BCL6 induced the T FH cell phenotype under nonpolarizing conditions and also in T cells already polar ized to T H 1, T H 2 and T H 17 cell phenotypes. Our feeling is that the induction of BCL6, through whatever means, may lead to the transformation of nonT FH effector T cells into T FH cells, with the consequent changes in cytokine and chemokine receptor expression.
J.J.o'S. various extrinsic factors contrib
ute to the plasticity of developing T H cells, including the cytokine milieu. Microbial pathogens and commensal bacteria also clearly influence the T cell environment. Retinoic acid is another classic differen tiating factor that has effects on multiple tissues; recent work has identified a role for retinoic acid in inhibiting the production of inflammatory cytokines and enhancing FOXP3 expression 43 . We also know that environmental factors that activate AHR influence T cell cytokine production. understanding how these extrinsic signals link to genetic and epigenetic regulation is obviously an important challenge.
Trying to define factors that influence lineage commitment versus plasticity is not new and not unique to T cells; arguments regarding determinism and flexibility have existed in developmental biology since the nineteenth century. Perhaps the most strik ing example of plasticity is the generation of inducible pluripotent stem cells by expres sion of a limited number of transcription factors 44, 45 . There are other examples of 'reprogramming' that do not require de differentiation to stem cells 46 ; for example, transfection of master regulators such as myoblast determination protein into termi nally differentiated cells can reprogramme them into muscle cells. Clearly, these are extreme and artificial circumstances; how ever, as we come to better understand the extrinsic signals that drive expression of transcription factors, we might be surprised by the plasticity that we see. As discussed ear lier, bivalent epigenetic marks on the genes encoding Tbet and GATA3 suggest that, with the appropriate extrinsic signals (that is, the right cytokines), reprogramming T cells might be easier than we thought. equally, we now know that epigenetic modifications are dynamic. For example, although trimethyla tion of histone 3 lysine 27 (H3K27) is assoc iated with repression of gene expression, H3K27 demethylases, such as jumonji d3 (JMJD3; also known as KDM6B) and uTX (also known as KDM6A), can remove repres sive marks. Consequently, induction of these demethylases provides another mechanism for plasticity. understanding the signals that induce these proteins and how they are recruited to some genes and not others will surely provide new insights into how phenotypes can be altered.
Why do we need so many functional subsets?
J.J.o'S. This is the easiest question to answer -we are surrounded by numerous different pathogens and commensal organisms and a changing environment. T cells traverse throughout the body in multiple niches to do their job. And they need to do this with out causing damage to the host. Flexibility makes a lot of sense; if new haematopoietic stem cells are continually generated, one might think that there is little need for flexi bility as new cells would be generated to deal with new circumstances. However, as the thymus involutes in the adult and de novo responses become limited with increasing age, flexibility of memory and effector T cell responses seems desirable. C.R.M. First, the immune system needs to respond to diverse pathogens and tumour cells, all of which are dealt with in different ways, involving different leukocyte types and different cytokines. Immunoglobulin pro duction is an important layer of immunity and requires dedicated T FH cells to migrate to follicles and regulate B cell selection, tol erance and immunoglobulin isotype switch ing. The products of the germinal centre reaction (that is, plasma cells, which produce highaffinity antibody) can be longlived, so control over this response must be stringent to avoid longterm autoimmunity. second, functional subsets need to operate in numer ous locations, and so subsets that operate in lymphoid tissues will be phenotypically distinct from those that function, for instance, at epithelial surfaces. IL4secreting T cells in follicles are probably functionally distinct from IL4secreting T cells in peripheral tissues 11 . 
B.S.
An obvious answer is that we need mul tiple effector pathways to deal with highly variable pathogen threats. In addition, adap tation of effector T cells to particular circum stances may be necessary in order to avoid side effects of immune reactions or to allow initiation of repair programmes following an immune response initiated to deal with a pathogen threat. This would necessitate changes in cytokine secretion patterns. Thus, the switch from IL4 to IL9 production may be linked with TGFβ and tissue remodelling, a switch from IL17 to IFNγ production dur ing autoimmune inflammation may indicate amelioration rather than exacerbation of disease, and IL10 production by T H 1 cells in infections may indicate a counterbalance to the proinflammatory response. Many immunologists (let alone non immunologists) are turned off by the prolif eration of T cell subsets with illogical names jumping from T H 1 and T H 2 to T H 9 or T H 17. Now that plasticity in effector profiles seems to be accepted, rather than conjecture, the old classifications as T H 1 cells and so on have lost their finality. For instance, IL9 is still regarded as a T H 2type cytokine in all textbooks, despite the fact that it is now clear that it is never coexpressed with IL4, IL5 or IL13 and its expression does not even correlate with GATA3 expression levels in polarized IL9producing T cells 3 . IL17 is not obligatorily coexpressed with IL22, and the fact that some cells may make only IL22 does not necessarily qualify them as T H 22 cells.
Nevertheless, it is difficult to prove that a given effector T cell that expresses a par ticular cytokine programme can turn on a different programme. Despite the fact that such claims were made from the beginning of the description of T H 17 cells, they were not assessed in a rigorous precursor-product manner until fairly recently 1, 2, 48, 49 . However, at present we do not know whether plasticity is limitless in any direction. until this has become clear, it will be difficult to replace the current unsatisfactory nomenclature with something more logical.
